World Health Organization Sounds Concern Over Critical Shortage of Weight-Loss Jabs
Fewer than one in 10 people eligible to benefit from obesity jabs like Wegovy have access to them, states the World Health Organization as it publishes its initial guidance on the therapies.
With more than one billion people worldwide currently classified as obese, it is calling for broader and more equitable access to this class of drugs.
Based on forecasts, over two billion could be living with obesity by 2030 without intervention.
"Our latest guidelines affirms that excess weight is a lifelong illness that can be treated with thorough and continuous treatment," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, insufficient output, and logistical bottlenecks are key obstacles to broad availability to the injections that can aid individuals in losing significant body mass, explains the agency.
Skinny Jab Shortage
Even under the present most favorable scenario, the production of GLP-1 therapies might only reach around 100 million people – under 10% of the global need, according to the WHO.
The advice urges governments and firms to expand availability, through approaches including voluntary licensing.
Exclusive production rights on semaglutide – the core component of a leading brand – is due to expire in several nations in 2026.
How Obesity Drugs Operate
These medications mimick a biological compound to delay gastric emptying, reduce hunger and enhance feelings of fullness so people consume fewer calories.
Individuals commonly begin shedding pounds in the initial weeks of beginning the regular doses.
Evidence suggests patients may regain a significant portion after a year of stopping the drug, as their normal hunger return.
To be carrying excess weight increases your chance for developing diseases, like type 2 diabetes, heart disease, brain attack, and specific cancers.
Excess weight impacts individuals in countries worldwide and was associated with millions of fatalities worldwide in 2024, according to the WHO.